Top 8 MS Research Advances of 2014
Eight top papers showcase scientific progress in multiple sclerosis research in 2014
A new year is a fine reason to gaze back on the accomplishments of...
Clinical Research, Drug Development, Laboratory Research
Drug Development
Data Visualization Displays 142 Ongoing MS Clinical Trials
Our latest data visualization allows you to sort the trials 10 different ways, including by phase, by population, by compound, and by sponsor
The image to the right comes from our latest data visualization, illustrating, as best as we can determine...
Clinical Research, Drug Development
MS Research Roundup: February 2, 2015
New Regulatory Gene for Myelin-Making Cells; Biogen + Google Team Up Against MS; Brainsmart Way to Quit Smoking
Items of interest to multiple sclerosis (MS) researchers from around the Web...
Clinical Research, Drug Development, Laboratory Research
MS Research Roundup: January 22, 2015
More Stem Cell Transplant Results; Less MS in Women With Ulcer-Causing Bacteria; Supreme Court Extends Wait for Generic Glatiramir Acetate; Research Drives Biotech Boom
Items of interest to multiple sclerosis researchers from around the Web...
Clinical Research, Drug Development
MS Research Roundup: January 18, 2015
Experimental Remyelination Antibody Results; This Is Your Brain on Diapers; Neuroscience With a Conscience
Items of interest to multiple sclerosis researchers from around the Web...
Clinical Research, Drug Development, Laboratory Research
Study Probes “No Evidence of Disease Activity” in MS Patients
“No evidence of disease activity,” or NEDA, means no clinical or MRI disease activity. As a treatment goal, the first study of NEDA in a “real-world” patient cohort shows plenty of room for improvement and a glimmer of hope.
Multiple sclerosis may as yet have no cure, but that’s not stopping a push to...
Clinical Research, Drug Development, Methods
MS Research Roundup: December 21, 2014
Neurology Group Calls for Cannabis Regulation Changes; Videos and Podcasts of MS Research and Care; Alan Alda & the MSDF Manifesto
Items of interest to multiple sclerosis researchers from around the Web...
Clinical Research, Drug Development
Azathioprine: Old Drug, New Data
Azathioprine may be as effective as interferon β in relapsing-remitting multiple sclerosis, a noninferiority trial suggests
Call it That ’80s Drug. Azathioprine (Immuran and others), a generic immunosuppressant, has been used...
Clinical Research, Drug Development, Methods
MS Research Roundup: December 12, 2014
The MS Blockbuster That Got Away; Playing Hardball With High-Priced Drugs; The Story of Gluten Intolerance
Items of interest to multiple sclerosis researchers from around the Web...
Clinical Research, Drug Development
MS Research Roundup: December 2, 2014
Fingolimod Falls Short for PPMS; Expanded U.S. Clinical Trial Data; New Neuroinflammatory T Cell Subset; Writing With Style
Items of interest to multiple sclerosis researchers from around the Web...
Clinical Research, Drug Development, Laboratory Research
Pages
